oDocs creates world-first AI medical platform for auto-diagnosis
Category: #health  By Dhananjay Punekar  Date: 2018-03-19
  • share
  • Twitter
  • Google Plus
  • Facebook
  • LinkedIn

oDocs creates world-first AI medical platform for auto-diagnosis

Dunedin firm oDocs, based in New Zealand, has apparently developed the world’s first AI-based medical platform for researchers & clinicians to determine various diseases based on a sole image. If reports are to be believed, the tool is operating effectively as of now and is now available for beta testing. The system has been apparently created for Medicmind.

Researchers claimed that this tech platform assists them in training a deep neural network for diagnosing automatic clinical images. According to MedicMind’S spokesperson, Glenn Linde, the AI based medical platform can assist the smartphone app to use a neural network for identifying the ailments such as diabetic eye disorder, glaucoma, and melanoma.

He further added that a lay individual can make use of a smartphone app and can diagnose a tumor themselves or a doctor can detect the eye degeneration through the image of the patient’s retina. Experts claim that MedicMind also helps the researchers to upload pictures for their AI training. They have further stated that physicians can take the neural network created on the platform and place it on a smartphone or any other device, which can then easily detect glaucoma via the image.

Dr. Hong Sheng Chiong, founder of Medicmind founder, stated that he had actually thought of a system that will guide the physicians and researchers to build AI without requiring to undergo any kind of training or study of programming or code writing. He was eager to make use of image classification of the 3D scans taken of each individual skull during Dunedin experiments for diagnosing anemia.

Linde has announced that he was not sure of developing the AI system, but felt confident that through the application of cloud computing technique, the AI based system can be developed for detecting various diseases through any mobile app or a device such as the desktop. Industry analysts believe that the new AI system will bring about a massive revolution in healthcare diagnostics and promote more medical & healthcare research.



About Author

Dhananjay Punekar

Email: dhananjay.p@news.marketsizeforecasters.com   

Dhananjay Punekar

Dhananjay Punekar presently develops content for a slew of portals, including Market Size Forecasters and Algosonline. A post graduate in mathematics and business administration, he worked in Infosys BPO Limited prior to switching his professional genre. As a content wr...

Read More

More News By Dhananjay Punekar

AstraZeneca gets import & marketing approval for Durvalumab in India
AstraZeneca gets import & marketing approval for Durvalumab in India
By Dhananjay Punekar

AstraZeneca Pharma India, a division of pharma & biopharma giant AstraZeneca plc, has received a green signal from the Indian drug regulating agency DCGI (Drug Controller General of India) for its drug Durvalumab c...

BP exits deal with Woolworths, retail firm looks out for alternatives
BP exits deal with Woolworths, retail firm looks out for alternatives
By Dhananjay Punekar

BP Plc, a UK based oil & gas firm, has decided to terminate its USD 1.8 billion acquisition deal with Australian retail giant Woolworths. For the record, the British oil & gas company had signed a pact to purch...

Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
Sarepta obtains positive results on DMD therapy, shares skyrocket 50%
By Dhananjay Punekar

The shares of Sarepta Therapeutics Inc., a medical research & drug development firm, climbed up by 50% after the firm released initial results derived from clinical treatment on patients suffering from Duchenne mus...